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Abstract 
Background: Retinal inflammation can cause retinal neural disorders. In particular, functional disorder in the cone 
photoreceptor system influences visual acuity. However, the underlying mechanism is not yet fully understood. In 
this study, we evaluated cone system function and the role of 5′-adenosine monophosphate-activated protein kinase 
(AMPK) during retinal inflammation.
Results: Six to eight-week-old male C57BL/6 mice received an intraperitoneal injection of lipopolysaccharide (LPS) 
to induce retinal inflammation, and were treated with an AMPK activator, 5-aminoimidazole-4-carboxamide ribonu-
cleoside (AICAR; 250 mg/kg body weight) or phosphate-buffered saline as vehicle 3 h before the LPS injection. The 
b-wave of the photopic electroretinogram, which represents cone system function, was decreased 24 h after LPS 
injection and this reduction was suppressed by AICAR treatment. At this time point, there was no remarkable mor-
phological change in the cone photoreceptor cells. At 1.5 h after LPS injection, the retina mRNA levels of an inflam-
matory cytokine, Tnf-α, were increased, and those of a regulator of mitochondrial biogenesis, Pgc1-α, were decreased. 
However, AICAR treatment suppressed these changes in mRNA expression. Immunohistochemistry showed that 
induction of glial fibrillary acidic protein expression was also suppressed by AICAR 24 h after LPS injection. Further-
more, the mouse cone photoreceptor-derived cell line 661W was treated with AICAR to increase the level of phos-
phorylated and activated AMPK. After 3 h of AICAR incubation, 661W cells showed decreased Tnf-α mRNA levels and 
increased Pgc1-α mRNA levels.
Conclusion: AMPK activation has a neuroprotective effect on cone system function during inflammation, and the 
effect may, at least in part, involve the regulation of inflammatory cytokines and mitochondrial condition.
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Background
Retinal inflammation is involved in the majority of reti-
nal diseases such as age-related macular degeneration 
and diabetic retinopathy, which seriously threaten vision. 
This is because inflammatory signaling in the retina can 
cause retinal neural disorders and visual disorders [1]. 
However, the molecular mechanism underlying reti-
nal inflammation and its consequent effects on vision 
is not fully understood, thus limiting the development 
of an effective therapeutic approach. Here, we focus on 
activated 5′-adenosine monophosphate-activated pro-
tein kinase (AMPK), an essential signaling molecule for 
cellular energy and mitochondrial homeostasis, which 
decreases in the retina during inflammation [2]. We pre-
viously demonstrated that the level of phosphorylated 
and activated AMPK was reduced and an inflammatory 
transcription factor, NF-κB, was activated in the retina 
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which indicates the retinal inflammation [2], and rod sys-
tem function is impaired in the endotoxin-induced uvei-
tis (EIU) mouse model induced by lipopolysaccharide 
(LPS) [2–5]. In this model, major blood vessels are dilated 
and monocytes adhere to them in the retina, which also 
indicates retinal inflammation [6–9]. However, whether 
cone system dysfunction is induced during inflammation 
has yet to be seen. In this study, we analyzed the photopic 
electroretinogram (ERG), which represents cone system 
function, during inflammation in the EIU mouse model, 




Six to eight-week-old male C57BL/6 mice (CLEA Japan, 
Tokyo, Japan) were maintained in an air-conditioned 
room under a 12-h dark/light cycle, with free access to 
food and water. The mice were randomly divided into 
three groups; control non-EIU with vehicle treatment, 
EIU with vehicle treatment, and EIU with AICAR treat-
ment groups. The mice received a single intraperito-
neal injection of 6.0 mg/kg body weight (BW) LPS from 
Escherichia coli (Sigma-Aldrich; St. Louis, MO, USA) 
in phosphate-buffered saline (PBS) to generate an EIU 
model which develops retinitis as well as uveitis [2–9]. 
The mice were treated with the specific AMPK activa-
tor 5-aminoimidazole-4-carboxamide ribonucleoside 
(AICAR; Santa Cruz Biotechnology; Santa Cruz, CA, 
USA) at 250 mg/kg BW or PBS as vehicle 3 h before the 
LPS injection. Reduction in the activated AMPK level 
during inflammation and its suppression by AICAR 
were confirmed previously [2]. All animal experiments 
were conducted in accordance with the Association for 
Research in Vision and Ophthalmology (ARVO) State-
ment for the Use of Animals in Ophthalmic and Vision 
Research and the protocol for this study was approved 
by the Keio University Institutional Animal Care and Use 
Committee (permission no. 08002) (Tokyo, Japan). For 
accuracy, all the experiments were repeated 2 or 3 times, 
but the number of the animals used in each experiment 
was minimized to follow the guideline. There were no 
important adverse events during the experiments.
Electroretinogram
The mice were anesthetized with 60 mg/kg BW of pento-
barbital sodium (Dainippon Sumitomo Pharmaceutical 
Co., Tokyo, Japan) and kept on a heating pad throughout 
the experiment. Photopic ERGs were recorded with con-
tact lens electrodes placed on the cornea (Mayo; Inazawa, 
Japan) after 10 min of light adaptation. Flash stimuli rang-
ing from 0.46 to 2.89 log cds m−2 were used for recording 
with a background of 30 cds m−2 (PowerLab System 2/25; 
AD Instruments; New South Wales, Australia), and the 
results of 20 single-flash trace trials were averaged. Eight 
mice for each group were used.
Real time RT‑PCR
Total RNA was isolated from the retina or the cell line 
(see below) with TRIzol reagent (Invitrogen, Carls-
bad, CA, USA) and was reverse-transcribed using the 
High Capacity RNA-to-cDNA Master Mix (Applied 
Biosystems; Foster City, CA, USA), according to the 
manufacturer’s instructions. Real-time polymerase 
chain reaction (PCR) was performed using the StepO-
nePlus™ Real-Time PCR system (Applied Biosystems), 
and the expression of the gene encoding the inflam-
matory cytokine tumor necrosis factor-alpha (Tnf-α) 
was quantified using the delta–delta cycle threshold 
method, and normalized to Gapdh expression. The 
forward and reverse primer sequences for Tnf-α were 
5′-GCCACCACGCTCTTCTGTCTA-3′ and 5′-GATG 
AGAGGGAGGCCATTTG-3′, those for peroxisome 
proliferator-activated receptor gamma coactivator 1-α 
(Pgc1-α) were 5′-GATGAATACCGCAAAGAGCA-3′ 
and 5′-AGATTTACGGTGCATTCCTCA-3′, and those 
for Gapdh were 5′-AACTTCGGCCCCATCTTCA-3′ 
and 5′-GATGACCCTTTTGGCTCCAC-3′. Six mice for 
each group were used to prepare the retinal samples, and 
6 samples of 661W cells in each group were analyzed.
Histochemistry
Retinal sections (10-μm thick) were fixed in 4  % para-
formaldehyde, and incubated with rhodamine-con-
jugated peanut agglutinin (Vector Laboratories; 
Burlingame, CA, USA) at room temperature for 1  h. 
Alternatively, they were incubated with rabbit anti-GFAP 
antibody (1:500; DAKO, Carpinteria, CA, USA) over-
night at 4 °C, followed by incubation with Alexa 488-con-
jugated goat anti-rabbit IgG at room temperature for 
1 h. All the sections were examined under a microscope 
equipped with a digital camera (Leica Microsystems, 
Wetzlar, Germany). Four mice for each group were used 
to prepare the retinal sections.
Culture
The 661W cells (a kind gift from Dr. Muayyad R. Al-
Ubaidi, University of Oklahoma Health Sciences Center, 
Oklahoma City, OK, USA) were maintained in Dulbec-
co’s modified Eagle’s medium (DMEM; Sigma-Aldrich, 
St. Louis, MO, USA) supplemented with 10  % fetal 
bovine serum, penicillin (100 units/ml), and streptomy-
cin (100 μg/ml) at 37 °C under a humidified atmosphere 
of 5 % CO2. The cells were incubated with either AICAR 
(0.5 or 1  mM) or vehicle in serum-free DMEM for 3  h. 
Six samples for each group were analyzed.
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Immunoblot analyses
Samples from the retina or the cell line were isolated and 
placed in lysis buffer, including protease inhibitor cock-
tail (Complete, EDTA-free; Roche, Mannheim, Germany) 
and phosphatase inhibitor cocktails 2 and 3 (Sigma-
Aldrich) to prepare the lysate, and immunoblot analyses 
were performed as described elsewhere [2]. Briefly, the 
proteins were separated by electrophoresis and electri-
cally transferred to a polyvinylidene fluoride membrane 
(Immobilon-P; Millipore; Bedford, MA, USA). The mem-
brane was blocked with 5  % skim milk in Tris-buffered 
saline with Tween or TNB blocking buffer [0.1 M Tris–
HCl, pH 7.5, 0.15 M NaCl, 0.5 % TSA Blocking Reagent 
(PerkinElmer Life Sciences; Waltham, MA, USA)], and 
then incubated overnight at 4  °C with a rabbit anti-
phospho-AMPKα (1:1000; Cell Signaling Technology) 
or rabbit anti-AMPKα (1:200; Cell Signaling Technol-
ogy) for normalization. Six samples for each group were 
analyzed.
Statistical analyses
All results are expressed as the mean  ±  SD. One-way 
ANOVA with Tukey’s post hoc test was used to assess the 
statistical significance of differences between the groups. 
P values <0.05 were considered as significant.
Results
Impairment of cone system function during inflammation 
and its suppression by AICAR
In these mice, we first evaluated the photopic ERG 24 h 
after LPS injection when rod photoreceptor responses 
in ERG had already been clearly reduced in this model 
[2]; Representative waveforms from an individual mouse 
in each group and means of each group are shown in 
Fig. 1a, b, respectively. The photopic ERG b-wave, which 
represents cone system function [10, 11], was decreased 
in the EIU model, and this reduction was suppressed by 
AICAR treatment (b-wave amplitudes in non-EIU with 
vehicle treatment, EIU with vehicle treatment, and EIU 
with AICAR treatment groups: 97.5 ± 41.2, 39.3 ± 34.7, 
and 71.6 ± 48.8 μV in response to 0.46  log cds m2 light 
stimuli; 185.5 ± 75.6, 80.5 ± 51.1, and 165.5 ± 48.0 μV 
in response to 1.39  log  cds  m2 stimuli; 243.0  ±  81.9, 
112.1  ±  86.6, and 233.7  ±  110.9  μV in response to 
2.89  log  cds  m2 stimuli) (Fig.  1a, b). Under this condi-
tion, rod photoreceptor cells are saturated and cannot be 
detected with light adaptation. These findings indicate 
that cone system dysfunction occurred during inflamma-
tion via reduced AMPK activation. Although the outer 
segment (OS) length is shortened in the rods during 
inflammation [2], the OS length of the cones was main-
tained in the current study. This was measured in the cry-
osections obtained 24 h after LPS injection that showed 
a positive reaction with the cone marker peanut aggluti-
nin (data not shown). Therefore, cone system dysfunction 
was observed in this inflammatory model, even without 
remarkable morphological changes.
Anti‑inflammatory effect of AICAR in the retina
Next, we analyzed the inflammatory signaling in the ret-
ina of the model mice with or without AICAR treatment. 
For this purpose, total RNA was isolated from the retina 
1.5 h after LPS injection; this is the time point when the 
inflammatory transcription factor, NF-κB, was activated 
in the retina in response to the reduction of activated 
AMPK, and this change was suppressed by AICAR, as 
we have previously shown [2]. The mRNA of Tnf-α was 
upregulated in the retina during inflammation (P < 0.01), 
and was suppressed by AICAR treatment (P  <  0.05) 
(Fig.  2a). Furthermore, mRNA expression levels were 
evaluated for a regulator of mitochondrial biogen-
esis, Pgc1-α, in the same retinal samples using real-time 
Fig. 1 Cone responses recorded by photopic electroretinogram 
during inflammation. Photopic electroretinogram (ERG) data 24 h 
after lipopolysaccharide (LPS) injection. a Representative photopic 
ERG waveforms from an individual mouse. b The b-wave amplitude 
showed significant reduction, which was prevented by 5-aminoimi-
dazole-4-carboxamide ribonucleoside (AICAR) treatment. All groups, 
n = 8. All results are expressed as the mean ± SD. One-way ANOVA 
with Tukey’s post hoc test was used to assess the statistical signifi-
cance of differences. P < 0.05 was regarded as significant. *P < 0.05. 
**P < 0.01
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PCR. Pgc1-α mRNA levels decreased during inflamma-
tion (P < 0.05), and were preserved by AICAR treatment 
(P < 0.05) (Fig. 2b).
We also analyzed expression of GFAP, a marker for 
reactive glia during retinal inflammation, by immuno-
histochemistry (Fig. 2c). We found that GFAP expression 
induced in the retina during inflammation was sup-
pressed by AICAR, suggesting that AICAR suppresses 
the inflammatory glial reaction in the retina.
Effect of AICAR on Tnf‑α and Pgc1‑α mRNAs in the 
photoreceptor cell line
To elucidate the role of AICAR in the cone photorecep-
tor cells, we performed in  vitro experiments using the 
mouse cone photoreceptor-derived cell line 661W. The 
levels of phosphorylated and activated AMPK in the 
cells incubated with either AICAR (0.5 mM or 1 mM) or 
vehicle in serum-free DMEM for 3 h were confirmed by 
immunoblot analyses. The level of activated AMPK was 
increased by AICAR treatment (P  <  0.05) (Fig.  3a, b). 
At the same time point, Tnf-α and Pgc1-α mRNA levels 
were measured by real-time PCR; Tnf-α levels decreased 
(P < 0.01) (Fig. 3c) and Pgc1-α levels increased (P < 0.01) 
(Fig. 3d) from the AICAR treatment.
Discussion
We demonstrated that cone system function was 
decreased after LPS injection. This reduction was sup-
pressed by AICAR treatment, although there was no 
remarkable morphological change in the cone photore-
ceptor cells. The retina mRNA levels of an inflammatory 
cytokine, Tnf-α, were increased, and those of a regulator 
Fig. 2 Anti-inflammatory effect of AICAR in the retina. a, b The retinal samples were obtained 1.5 h after lipopolysaccharide (LPS) injection and 
subjected to real-time polymerase chain reaction (PCR). a The mRNA level of Tnf-α was increased in the retina, and the increase was significantly 
suppressed by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) treatment. b The mRNA level of Pgc1-α in the retina was decreased in the 
endotoxin-induced uveitis (EIU) model, and this decrease was attenuated by AICAR. c Immunohistochemistry showing that the enhanced expres-
sion of glial fibrillary acidic protein (GFAP) in the retina 24 h after LPS injection was suppressed by AICAR treatment. a–c All groups, n = 6. a, b All 
results are expressed as the mean ± SD. One-way ANOVA with Tukey’s post hoc test was used to assess the statistical significance of differences. 
P < 0.05 was regarded as significant. *P < 0.05. **P < 0.01
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of mitochondrial biogenesis, Pgc1-α, were decreased at 
the earlier time point after LPS injection. Immunohisto-
chemistry showed that induction of GFAP expression was 
also suppressed by the time point when cone system dys-
function was recorded. However, AICAR treatment sup-
pressed all these changes in the EIU mice. Furthermore, 
in the mouse cone photoreceptor-derived cell line 661W, 
induction of activated AMPK by AICAR decreased Tnf-α 
mRNA levels and increased Pgc1-α mRNA levels.
Given that TNF-α-induced neurotoxicity can be medi-
ated by rapid mitochondrial dysfunction [12], the cone 
system dysfunction during inflammation may be related 
to this pathway; in fact, in this study, Tnf-α was induced 
and Pgc1-α was repressed during the inflammation that 
caused cone system dysfunction. Moreover, AMPK acti-
vation played a direct role in suppressing these effects, 
suggesting a critical role of activated AMPK. The mecha-
nism suggested by these results is as follows: reduction in 
activated AMPK may induce an inflammatory cytokine, 
TNF-α, during inflammation, which would disrupt mito-
chondrial homeostasis, at least in part, in the cone pho-
toreceptor cells, thereby impairing cone system function 
during retinal inflammation. AMPK activation may be an 
intrinsic self-defense mechanism for cone photoreceptor 
cells to maintain a healthy condition, and any breakdown 
of this mechanism during inflammation would lead to 
dysfunction.
Furthermore, the fact that GFAP expression induced 
during inflammation was also suppressed by AICAR 
implicates an indirect role for Müller glial cells in the 
neuroprotective effect on the cone photoreceptor neu-
rons during inflammation. TNF-α can be expressed by 
both photoreceptors and Müller glial cells [13]. None-
theless, the present in vitro results suggest a direct effect 
of AMPK activation, at least in part, in the protection of 
cone photoreceptor neurons.
Functional impairment in our model could have pre-
ceded any visible morphological damage, although 
minimum architectural changes cannot be excluded. 
The discrepancy between function and morphology is 
not uncommon in human subjects with uveitis [14]. 
Indeed, Holder et  al. [14] reported that the cone func-
tional damage preceded morphological changes in 
patients with inflammatory disorders, and, in some cases, 
Fig. 3 The effect of AICAR on Tnf-α and Pgc1-α expression. a–d The samples of 661W cells were obtained 3 h after incubation with AICAR. a, b 
Immunoblot analyses. The level of phospho-5′-adenosine monophosphate-activated protein kinase (AMPK) was upregulated with AICAR treatment 
at concentrations of 0.5 mM and 1 mM. c, d Real-time PCR. The mRNA level of Tnf-α was decreased (c) and that of Pgc1-α was increased (d) by AICAR 
treatment. All groups, n = 6. All results are expressed as the mean ± SD. One-way ANOVA with Tukey’s post hoc test was used to assess the statisti-
cal significance of differences. P < 0.05 was regarded as significant. *P < 0.05. **P < 0.01
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improvement following treatment preceded visible clini-
cal signs of recovery. This indicates that an inflammatory 
reaction can cause cone system dysfunction, which may 
cause central visual impairment in humans even with no 
marked architectural alteration. Thus, cone system dys-
function could be an early sign of inflammatory disease, 
as well as a sensitive parameter for measuring treatment 
efficacy, although the findings in the current study were 
obtained from mice and not human, thus further study is 
required to fully discuss the human findings.
Conclusion
Cone system dysfunction may occur during inflamma-
tion, at least in part, through decreased levels of activated 
AMPK. An AMPK activator, AICAR, protected the func-
tion of the cone photoreceptor system during inflam-
mation, repressing an inflammatory cytokine, Tnf-α, 
and preserving a regulator of mitochondrial biogenesis, 
Pgc1-α. These results suggest that preserving activated 
AMPK levels in the retina may be a new therapeutic 
approach for protecting cone system function during 
inflammation.
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